FluroTech Ltd. (FLURF) Research

FluroTech Ltd. operates as a technology and marketing firm, primarily focused on advancing and commercializing various innovations within the pandemic defense industry. The company is responsible for developing the FluroTest SARS-CoV-2 diagnostic, which is designed to pinpoint patients with active viral infections. Its headquarters are located in Calgary, Canada.

Market snapshot

Symbol
FLURF
Price
$0.00
Market cap
$634.0K
P/E ratio
-2.40x
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Achiko AG (ACHKF)
  • Alseres Pharmaceuticals, Inc. (ALSE)
  • Aquarius Surgical Technologies Inc. (AQQRF)
  • Evolva Holding S.A. (ELVAY)
  • Laxai Pharma, Ltd. (LAXAF)
  • Evome Medical Technologies Inc. (LNDZF)
  • Lotus Ventures Inc. (LTTSF)
  • Medical Services International Inc. (MSITF)

Open FluroTech Ltd. (FLURF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.